Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
CJC-1295 is hypothesized to bind to GHRH receptors on pituitary somatotroph cells potentially inducing a conformational change that initiates intracellular signaling events including the activation of G-proteins, production of secondary messengers such as cAMP and IP3, and ultimately the fusion of growth hormone-containing vesicles with the plasma membrane and their release into the extracellular environment in laboratory models
Treatment of rosacea with herbal ingredients
Reported targets & pathways GHRH receptor Ghrelin / GHS-R1a receptor Pituitary somatotroph GH release IGF-1 axis Selected research Published studies on CJC-1295 + Ipamorelin Blend Peer-reviewed references for further reading
Taken together, our data indicate that the loss of GSH triggered by Gclc deletion induces a defective mitochondrial accumulation in FoB, which may lead to compensation through upregulation of glycolytic metabolism
US$ 28.59
US$ 29.95
US$ 20.73
US$ 24.21
US$ 25.20
US$ 25.71
US$ 28.71
US$ 26.78
US$ 21.48
US$ 29.80
US$ 20.15
